Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Pfizer
Business Segments
Products & Services
Finite-lived intangible assets, period increase
Finite-lived intangible assets, period increase
Pfizer
·
Products & Services
·
2 segments
·
Rolls up to
Intangible assets, increase (decrease)
Breakdown
Segments
Tukysa
View metric
Padcev
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Tukysa
—
—
—
—
$580M
Padcev
$150M
$150M
$150M
$150M
—
Total
—
—
—
—
—
Padcev is derived from annual filings.